Irinotecan Hydrochloride Trihydrate
CAS:136572-09-3
Basic Information | |
Product Name | Irinotecan Hydrochloride Trihydrate |
Other Name | Irinotecan |
Specification | 99% |
Appearance | Pale yellow crystalline powder |
CAS NO. | 136572-09-3 |
Molecular Formula | C33H45ClN4O9 |
Molecular Weight | 677.18 |
Standard | USP 34 |
Structure | |
Function | |
Irinotecan Hydrochloride Trihydrate is used for the treatment of digestive tumors such as stomach cancer, colon cancer, colorectal cancer, lung cancer; and also for the treatment of leukemia, mole and choriocarcinoma.
| |
Application | |
Irinotecan Hydrochloride Trihydrate is used for the preparation of injection Pharmaceutical raw materials
| |
Packing | |
100g/bag or as your requirement | |
Storage | |
Preserve in tight, light resistant containers at 2℃ - 8℃. | |
Shelf life | |
24 months when properly stored. |
CERTIFICATE OF ANALYSIS
Appearance | Pale yellow crystalline powder |
Identification | IR HPLC Chlorides |
Microbial enumeration tests | ≤100cfu/g |
Water determination | 7.0%~9.0% |
Residue on ignition | ≤0.1% |
Heavy metals | ≤10ppm |
Residual solvent | |
Methanol | ≤3000 ppm |
Dichloromethane | ≤600 ppm |
Methylbenzene | ≤890 ppm |
Ethanol | ≤5000 ppm |
Pyridine | ≤200 ppm |
Related substances | |
Irinotecan related compound B | ≤0.15% |
Irinotecan related compound C | ≤0.10% |
Any unspecified impurity | ≤0.10% |
Total impurities | ≤0.5% |
Chiral impurity(R-enantiomer) | ≤0.15% |
Assay(on anhydrous basis) | 98.0%~102.0% |